Proliferative diabetic retinopathy in patients with type 2 diabetes correlates with the presence of atherosclerosis cardiovascular disease

Table 2 Odds ratios of metabolic factors for ASCVD

	B	SE	Wald	OR	95% CI	P value
Age (per 10 years)	0.595	0.187	10.141	1.814	1.257–2.616	0.001
Sex (f/m)	0.679	0.302	5.053	1.971	1.091–3.562	0.025
Smoking (y/n)	− 0.649	0.351	3.423	0.522	0.263–1.039	0.064
Alcohol (y/n)	− 0.822	0.350	5.526	0.440	0.222–0.872	0.019
High education (y/n)	0.007	0.561	0.000	1.007	0.335–3.026	0.989
Physical activity (y/n)	0.024	0.327	0.005	1.024	0.539–1.946	0.942
Family history of ASCVD (y/n)	0.615	0.272	5.103	1.850	1.085–3.155	0.024
Central obesity (y/n)	0.677	0.351	3.723	1.967	0.989–3.913	0.054
General obesity
Overweight (y/n)	− 0.111	0.334	0.110	0.895	0.466–1.721	0.740
Obesity (y/n)	− 0.174	0.363	0.228	0.841	0.412–1.714	0.633
Duration of DM (y/n)	0.031	0.039	0.661	1.032	0.957–1.113	0.416
FPG (per 1 mmol/l)	0.158	0.090	3.068	1.171	0.981–1.396	0.080
HbA1c (per 1 %)	0.181	0.068	7.174	1.198	1.050–1.368	0.007
Hypertension (y/n)	0.311	0.343	0.824	1.365	0.697–2.674	0.364
SBP (per 10 mmHg)	0.051	0.066	0.597	1.052	0.925–1.197	0.440
DBP (per 5 mmHg)	− 0.037	0.060	0.368	0.964	0.857–1.085	0.544
TC (≥ 4.68 mmol/l)	− 0.080	0.302	0.071	0.923	0.510–1.668	0.790
TG (≥ 1.70 mmol/l)	− 0.029	0.274	0.011	0.971	0.568–1.660	0.915
LDL-C (≥ 2.60 mmol/l)	0.622	0.362	2.959	1.864	0.917–3.788	0.085
HDL-C (m ≤ 1.00 mmol/l; f ≤ 1.30 mmol/l)	0.217	0.323	0.453	1.243	0.660–2.341	0.501
eGFR (per 10 ml/min/1.73 m²)	− 0.105	0.043	5.910	0.900	0.827–0.980	0.015

Binary univariate logistic regression was conducted to assess the association of ASCVD with different variables using the Entry method; odds ratios (ORs) and the 95% confidence intervals (CIs) given

ISSN: 1758-5996